Andere Sprachen Cellebrite DI Ltd.

Aktien

A3D00S

IL0011794802

CLBT

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:51:17 07.06.2024			% 5 Tage	% 1. Jan.
10,54 ^USD	-0,09 %		-1,27 %	+21,42 %

24.05.	CELLEBRITE DI LTD. : Bewertung von JPMorgan Chase zum Kaufen erhalten	ZM
24.05.	CELLEBRITE DI LTD. : Bewertung von Deutsche Bank Securities kaufen	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Cellebrite's Q1 Non-GAAP Earnings, Revenue Increase	23.05.
Earnings Flash (CLBT) CELLEBRITE DI Reports Q1 Revenue $89.6M, vs. Street Est of $85.4M	23.05.
Earnings Flash (CLBT) CELLEBRITE DI Reports Q1 EPS $0.08, vs. Street Est of $0.06	23.05.
Cellebrite Announces First-Quarter 2024 Results	23.05.
Cellebrite Announces First-Quarter 2024 Results	23.05.
Cellebrite DI Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23.05.
Cellebrite Di Ltd. Provides Earnings Guidance for Second-Quarter of 2024 and Reaffirms Earnings Guidance for the Full Year 2024	23.05.
Cellebrite Announces Participation in Upcoming Investor Conferences	16.05.
Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024	10.04.
Cellebrite révolutionne la collecte de données avec une solution SaaS révolutionnaire faisant partie intégrante de la plateforme Case-to-Closure de l’entreprise	26.03.
Cellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market Leadership	25.03.
Cellebrite DI Ltd. Announces the Appointment of David Gee as Chief Marketing Officer	25.03.
Cellebrite Files its 2023 Annual Report on Form 20-F	21.03.
Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform	14.03.
Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform	14.03.
Cellebrite DI Ltd. Unveils Cellebrite Endpoint Inspector SaaS	14.03.
Cellebrite DI Shares Rise After William Blair Upgrades Stock to Outperform From Market Perform	13.03.
UPDATE – Cellebrite Announces 2024 Investor Day	12.03.
UPDATE – Cellebrite Announces 2024 Investor Day	12.03.
Cellebrite Launches FedRAMP Authorization Process for SaaS Offerings	07.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cellebrite DI Ltd.

Aktien

A3D00S

IL0011794802

CLBT

Andere Sprachen

Filter